Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial

Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry v3.3.2 and removes v3.3.1, a minor version-label change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:46:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    New revision label added: Revision: v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:14:11.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding notice was removed from the page history; core study details and records remain the same.
    Difference
    0.7%
    Check dated 2025-11-17T06:12:36.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The old and new screenshots show the same page content with no substantive updates to study details, status, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:45:38.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version upgrade to v3.2.0; removed the previous v3.1.0 marker.
    Difference
    12%
    Check dated 2025-10-05T04:53:04.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T02:48:22.000Z thumbnail image

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.